Bone Therapeutics fa
Bone Therapeutics fait le point sur ses activités du premier trimestre 2021
26 mai 2021 01h00 HE | Bone Therapeutics SA
INFORMATION RÉGLEMENTÉE Des avancées cliniques solides, notamment dans l’étude de Phase III évaluant le JTA-004 grâce aux niveaux élevés d’observance et d’adhésion des patients ...
Bone Therapeutics Pr
Bone Therapeutics Provides First Quarter 2021 Business Update
26 mai 2021 01h00 HE | Bone Therapeutics SA
REGULATED INFORMATION Strong clinical progress especially in JTA-004 Phase III study thanks to high patient compliance and retention Process development partnership and appointment of cell...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Brazilian Health Regulatory Agency (ANVISA) Authorizes Sorrento Phase 2 Pivotal Clinical Trial of COVI-MSC™ in Hospitalized COVID-19 Patients With Acute Respiratory Distress Syndrome
20 mai 2021 09h00 HE | Sorrento Therapeutics, Inc.
Brazil Phase 2 Pivotal clinical trial of COVI-MSC is now authorized to proceed.The study will compare therapy using mesenchymal stem cells to placebo (and standard of care) in 100 COVID-19 patients...
Studio City Logo_v3 (1).jpg
Studio City Finance Announces Pricing of 5.000% Senior Notes Offering
11 mai 2021 14h40 HE | Studio City
MACAU, May 11, 2021 (GLOBE NEWSWIRE) -- Studio City Finance Limited (“Studio City Finance”) announces that it has priced its international offering of 5.000% senior notes due 2029 (the “Additional...
Studio City Logo_v3 (1).jpg
Studio City Finance Announces Proposed 5.000% Senior Notes Offering
10 mai 2021 06h56 HE | Studio City
MACAU, May 10, 2021 (GLOBE NEWSWIRE) -- Studio City Finance Limited (“Studio City Finance”) announces that it proposes to conduct an international offering of 5.000% senior notes due 2029 (the...
Bone Therapeutics ti
Bone Therapeutics tiendra son Assemblée Générale Ordinaire le 9 juin 2021
07 mai 2021 01h00 HE | Bone Therapeutics SA
INFORMATION RÉGLEMENTÉE Mise à disposition des documents préparatoires à l’assemblée générale ordinaire sur le site internet de la Société Gosselies, Belgique, le 7 mai 2021 à...
Bone Therapeutics to
Bone Therapeutics to host Annual General Meeting on 9 June 2021
07 mai 2021 01h00 HE | Bone Therapeutics SA
REGULATED INFORMATION Preliminary documents for the Annual General Meeting have been made available on company’s website Gosselies, Belgium, 7 May 2021, 7am CEST – BONE THERAPEUTICS (Euronext...
Studio City Logo_v3 (1).jpg
Studio City International Holdings Limited Announces Unaudited First Quarter 2021 Earnings
28 avr. 2021 08h26 HE | Studio City
MACAU, April 28, 2021 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC) (“Studio City” or the “Company”), a world-class integrated resort located in Cotai, Macau, today...
Studio City Logo_v3 (1).jpg
Studio City Announces Earnings Release Date
21 avr. 2021 08h07 HE | Studio City
MACAU, April 21, 2021 (GLOBE NEWSWIRE) -- Studio City International Holdings Limited (NYSE: MSC), a world-class integrated resort located in Cotai, Macau, today announces that it will furnish its...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Announces Positive Results of Phase 1b Study of COVI-MSC™ Treatment of ICU Covid-19 Patients, Achieving 100% (10 out 10) Discharge Rate
20 avr. 2021 09h00 HE | Sorrento Therapeutics, Inc.
The target enrollment of 10 patients with acute respiratory failure due to COVID-19 has been accomplished.All 10 patients were discharged from hospital within three days after their last COVI-MSC...